Peptech ASX: PTD - Peptech Presentation To Eg Capital Forum - Dr John Chiplin, CEO
Sydney, July 12, 2007 (ABN Newswire) - Peptech (ASX: PTD) - Peptech presentation to eG Capital Forum - Dr John Chiplin, CEO; Peptech (ASX: PTD) present the following audio webcast regarding "Peptech presentation to eG Capital Forum". You may also download this audio webcast to your computer of portable audio player.
Broadcaster: Peptech (ASX: PTD)
Broadcast Title: Peptech presentation to eG Capital Forum
Broadcast Type: Audio stream
Audio webcast Link:
Listen to the Audio stream and view the announcement for Peptech (ASX: PTD) below.
Peptech Limited focuses on the research and development of peptides and proteins in the areas of human pharmaceuticals and animal health. Peptech holds a 36.1 per cent shareholding in Domantis, a UK-based drug development company, and has formed a 50/50 joint venture company with Biosceptre. The company is positioned to become a globally recognised leader in biopharmaceutical development. For more information, please visit www.peptech.com.
About Arana Therapeutics Limited
Undertake research, development, production, formulation and marketing of peptides, and related products for the the pharmaceutical, veterinary and agricultural industries.
